21 related articles for article (PubMed ID: 31612639)
1. Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors.
Friedes C; Iocolano M; Lee SH; Li B; Duan L; Levin WP; Cengel KA; Sun LL; Aggarwal C; Marmarelis ME; Doucette A; Cohen RB; Xiao Y; Langer CJ; Bradley J; Feigenberg SJ; Yegya-Raman N
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1435-1444. PubMed ID: 37866762
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
Raturi V; Hojo H; Bhatt MLB; Suhel M; Wu CT; Bei Y; Nakamura M; Okumura M; Zhang H; Parmar D; Badajena A; Singh R; Kumar S; Katiyar T; Gaur J
Head Neck; 2020 May; 42(5):1045-1056. PubMed ID: 31997432
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM; Noronha V; Joshi A; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; Mahimkar M; Juvekar S; Arya S; Mahajan A; Agarwal A; Purandare N; Rangarajan V; Balaji A; Chaudhari SV; Banavali S; Kannan S; Bhattacharjee A; D'Cruz AK; Chaturvedi P; Pai PS; Chaukar D; Pantvaidya G; Nair D; Nair S; Deshmukh A; Thiagarajan S; Mathrudev V; Manjrekar A; Dhumal S; Maske K; Bhelekar AS; Nawale K; Chandrasekharan A; Pande N; Goel A; Talreja V; Simha V; Srinivas S; Swami R; Vallathol DH; Dsouza H; Shrirangwar S; Turkar S; Abraham G; Thanky AH; Patel U; Pandey MK; Prabhash K
Cancer; 2019 Sep; 125(18):3184-3197. PubMed ID: 31150120
[TBL] [Abstract][Full Text] [Related]
4. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
[TBL] [Abstract][Full Text] [Related]
5. Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Sun H; Zimmermann F; Bodis S; Bernier J; Studer G; Aebersold DM;
Oral Oncol; 2013 Oct; 49(10):1006-9. PubMed ID: 23916716
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients.
Chitapanarux I; Lekawanvijit S; Sripan P; Mahanupab P; Chakrabandhu S; Onchan W; Sittitrai P; Boonlert D; Klibngern H; Samuckkeethum W
J Res Med Sci; 2020; 25():34. PubMed ID: 32582340
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
8. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy?
Loo SW; Geropantas K; Roques TW
Clin Oncol (R Coll Radiol); 2013 May; 25(5):298-307. PubMed ID: 23290343
[TBL] [Abstract][Full Text] [Related]
9. Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?
Raturi VP; Wu CT; Mohammad S; Hojo H; Bei Y; Nakamura M; Okumura M; Rachi T; Singh R; Gupta R; Parmar D; Hasan F; Gaur J; Kishan D; Kumar S; Badajena A; Katepogu P; Shigematsu N
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e19-e26. PubMed ID: 31612639
[TBL] [Abstract][Full Text] [Related]
10. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
